Literature DB >> 2671582

Virulence and vaccine potential of phoP mutants of Salmonella typhimurium.

J E Galán1, R Curtiss.   

Abstract

We have constructed Salmonella typhimurium phoP mutants and found them to be avirulent and able to induce a protective immune response. BALB/c mice survived challenge with phoP derivatives of the highly virulent S. typhimurium strains SR-11 and SL1344 when inoculated intraperitoneally and per oral with doses equivalent to 10(4) 50% lethal doses (LD50) of the parent virulent strains. The avirulent mutants were able to establish an infection of the Peyer's patches of orally infected animals for up to 10 days after inoculation but were very inefficient at reaching the spleens. Despite the low level of infectivity of these mutants, immunized animals developed a delayed-type hypersensitivity (DTH) response to Salmonella antigens and resisted challenge with up to 10(4) LD50 of the virulent parent strain 30 days after immunization.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2671582     DOI: 10.1016/0882-4010(89)90085-5

Source DB:  PubMed          Journal:  Microb Pathog        ISSN: 0882-4010            Impact factor:   3.738


  80 in total

Review 1.  The pleiotropic two-component regulatory system PhoP-PhoQ.

Authors:  E A Groisman
Journal:  J Bacteriol       Date:  2001-03       Impact factor: 3.490

2.  Subversion of innate and adaptive immune activation induced by structurally modified lipopolysaccharide from Salmonella typhimurium.

Authors:  Rodolfo Pastelin-Palacios; Cristina Gil-Cruz; Christian I Pérez-Shibayama; Mario A Moreno-Eutimio; Luisa Cervantes-Barragán; Lourdes Arriaga-Pizano; Burkhard Ludewig; Adam F Cunningham; Eduardo A García-Zepeda; Ingeborg Becker; Celia Alpuche-Aranda; Laura Bonifaz; John S Gunn; Armando Isibasi; Constantino López-Macías
Journal:  Immunology       Date:  2011-06-02       Impact factor: 7.397

3.  Phenotype microarray analysis of Escherichia coli K-12 mutants with deletions of all two-component systems.

Authors:  Lu Zhou; Xiang-He Lei; Barry R Bochner; Barry L Wanner
Journal:  J Bacteriol       Date:  2003-08       Impact factor: 3.490

4.  Expression of Escherichia coli virulence usher protein attenuates wild-type Salmonella.

Authors:  Xinghong Yang; Zhiyong Suo; Theresa Thornburg; Kathryn Holderness; Ling Cao; Timothy Lim; Nancy Walters; Laura Kellerman; Linda Loetterle; Recep Avci; David W Pascual
Journal:  Virulence       Date:  2012-01-01       Impact factor: 5.882

Review 5.  Recombinant avirulent salmonellae as oral vaccine carriers.

Authors:  F Schödel
Journal:  Infection       Date:  1992 Jan-Feb       Impact factor: 3.553

6.  Optimization of the delivery of heterologous proteins by the Salmonella enterica serovar Typhimurium type III secretion system for vaccine development.

Authors:  Li-Mei Chen; Gabriel Briones; Ruben O Donis; Jorge E Galán
Journal:  Infect Immun       Date:  2006-10       Impact factor: 3.441

7.  Immunological responses against Salmonella enterica serovar Typhimurium Braun lipoprotein and lipid A mutant strains in Swiss-Webster mice: potential use as live-attenuated vaccines.

Authors:  Tie Liu; Rolf König; Jian Sha; Stacy L Agar; Chien-Te K Tseng; Gary R Klimpel; Ashok K Chopra
Journal:  Microb Pathog       Date:  2007-10-06       Impact factor: 3.738

8.  Transcriptional autoregulation of the Salmonella typhimurium phoPQ operon.

Authors:  F C Soncini; E G Véscovi; E A Groisman
Journal:  J Bacteriol       Date:  1995-08       Impact factor: 3.490

9.  Macrophage-inducible expression of a model antigen in Salmonella typhimurium enhances immunogenicity.

Authors:  E L Hohmann; C A Oletta; W P Loomis; S I Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-03-28       Impact factor: 11.205

10.  Molecular and functional characterization of Salmonella enterica serovar typhimurium poxA gene: effect on attenuation of virulence and protection.

Authors:  K Kaniga; M S Compton; R Curtiss; P Sundaram
Journal:  Infect Immun       Date:  1998-12       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.